Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) vs Tempus ECG-AF
AI Verdict
Choose Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) if…
Choose Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) if your patient requires continuous, real-time monitoring for life-threatening arrhythmias and immediate, automated defibrillation therapy outside of a hospital setting. This device is ideal for individuals needing a discreet, highly compliant wearable solution that can detect and treat dangerous heart rhythm disturbances, ensuring protection during daily activities.
View Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if you need to proactively identify patients aged 65 or older who are at increased risk of developing new-onset atrial fibrillation within the next year, based on a standard 12-lead ECG. This AI-powered software is best suited for risk stratification and guiding earlier follow-up or preventative strategies in asymptomatic or undiagnosed elderly populations.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) | Tempus ECG-AF |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | Wearable device with mobile app | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)Tool A, the Jewel Patch, demonstrates superior patient usability through its discreet, water-resistant, patch-based design, which facilitates continuous wear and high patient compliance (over 23 hours/day). This focus on patient experience is critical for a wearable therapeutic device, directly addressing ease of use and adherence in a real-world setting.
Clinical Value
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)Tool A offers direct therapeutic intervention by continuously monitoring for and treating life-threatening arrhythmias, which provides immediate and critical clinical value in saving lives. While Tool B offers valuable risk stratification for future AF development, Tool A's capability to detect and treat acute, life-threatening conditions represents a more immediate and high-impact clinical benefit.
Pricing & Value
Tempus ECG-AFTool B provides greater transparency regarding its financial value proposition by detailing CMS reimbursement availability, including specific CPT codes and a Medicare rate. This information allows healthcare providers to better assess the economic viability and integration of the solution, whereas Tool A's pricing details are not publicly available.
Enterprise Readiness
Tempus ECG-AFTool B explicitly states 'yes' for both BAA and HIPAA compliance and is deployed as a software solution integrated into healthcare facility systems, indicating a streamlined fit into existing enterprise IT infrastructure. Tool A's compliance statements are slightly less definitive ('likely' and 'expected') for its associated digital platforms, and its hardware component might introduce additional deployment complexities for an enterprise.
Innovation
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)Tool A showcases significant innovation by transforming the traditional, often cumbersome, wearable cardioverter defibrillator into a discreet, water-resistant patch with high patient compliance, leveraging machine learning for detection. This addresses a critical unmet need in patient experience and adherence for a life-saving device, representing a substantial advancement in medical device design and patient care.
Support & Docs
TieNeither the provided structured facts nor general web searches offer sufficient specific details about the scope, quality, or availability of support and documentation for either tool to definitively pick a winner. Both companies maintain professional websites with information for users, but comparative details are lacking.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) | Tempus ECG-AF |
|---|---|---|
| Name | Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) | Tempus ECG-AF |
| Company | Element Science, Inc. | Tempus AI, Inc. |
| Description | The Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) is a water-resistant, patch-based device with a machine learning algorithm for continuous heart monitoring and treatment of life-threatening arrhythmias, designed for high patient compliance. | Tempus ECG-AF is an FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. |
| Key Functionality | Continuous heart rhythm monitoring; detects and treats specific life-threatening arrhythmias. | AI-based algorithm for 12-lead ECG analysis; detects signs associated with new onset Atrial Fibrillation (AF) within 12 months. |
| Target Patient Population | Not specified | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI |
Videos
Demos, reviews, and walkthroughs featuring Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) and Tempus ECG-AF.